C

Candel Therapeutics

71 employees

Candel Therapeutics develops cancer immunotherapies designed to improve the lives of cancer patients and their families.

Basic info

Industry

biotechnology research

Sectors

Health Diagnostics
Biotechnology
Health Care
Therapeutics
Viral Immunotherapy
Genetics
Oncology
Prostate Cancer
Medical
Brain Cancer
Immuno-oncology

Date founded

1999

Funding rounds raised

Total raised

$29M

from 4 investors over 4 rounds

C

Candel Therapeutics raised $23M on April 1, 2019

Investors: Northpond Ventures and Sands Capital Management

C

Candel Therapeutics raised $29M on January 4, 2019

Investors: PBM Capital Group

C

Candel Therapeutics raised $500K on May 25, 2011

Investors: Massachusetts Life Sciences Center

FAQ